single-use test cartridges i-stat alinity base station Search Results


advia chemistry xpt analyzer  (Siemens AG)
90
Siemens AG advia chemistry xpt analyzer
Weeks 1 to 4 (combined) blood measurements of patient kidney function (potassium and <t> creatinine), </t> measured by the patient and clinic use of i-STAT and the laboratory
Advia Chemistry Xpt Analyzer, supplied by Siemens AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/single-use+test+cartridges+i-stat+alinity+base+station/pmc10239793-50-21-52?v=Siemens+AG
Average 90 stars, based on 1 article reviews
advia chemistry xpt analyzer - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Weeks 1 to 4 (combined) blood measurements of patient kidney function (potassium and creatinine), measured by the patient and clinic use of i-STAT and the laboratory

Journal: Kidney International Reports

Article Title: Patient Self-Testing of Kidney Function at Home, a Prospective Clinical Feasibility Study in Kidney Transplant Recipients

doi: 10.1016/j.ekir.2023.03.003

Figure Lengend Snippet: Weeks 1 to 4 (combined) blood measurements of patient kidney function (potassium and creatinine), measured by the patient and clinic use of i-STAT and the laboratory

Article Snippet: A prospective, observational, single-center, clinical feasibility study (TRN: ISRCTN68116915), with N = 15 stable kidney transplant recipients, investigated blood potassium and creatinine results agreement between index self-tests at home (patient self-testing of capillary blood, using Abbott i-STAT Alinity analyzers [i-STAT]) and reference tests in clinic (staff sampled venous blood, analyzed with laboratory Siemens Advia Chemistry XPT analyzer) using Bland-Altman and error grid analysis.

Techniques:

Bland-Altman plot of creatinine (unit = μmol/l) showing the difference for each patient, at each time point, between the i-STAT at home (capillary blood) and standard laboratory testing (venous blood), plotted against the mean of the 2 tests. The dashed reference line (y = 0) represents zero difference between tests (i.e., perfect agreement), the 2 dot-dash lines (y = 16.81, −12.31) represent the 95% confidence interval for differences between pairs of individual measurements, and the 2 solid lines (y = 25, y = −25) represent the clinical acceptability criteria. Participant ID has been used as the data-point symbol. Green symbols represent clinically acceptable differences between measures (i.e., data points located in-between the 2 solid lines), whereas red symbols represent clinically unacceptable differences (i.e., data points located outside the 2 solid lines); there are no clinically unacceptable paired results for creatinine.

Journal: Kidney International Reports

Article Title: Patient Self-Testing of Kidney Function at Home, a Prospective Clinical Feasibility Study in Kidney Transplant Recipients

doi: 10.1016/j.ekir.2023.03.003

Figure Lengend Snippet: Bland-Altman plot of creatinine (unit = μmol/l) showing the difference for each patient, at each time point, between the i-STAT at home (capillary blood) and standard laboratory testing (venous blood), plotted against the mean of the 2 tests. The dashed reference line (y = 0) represents zero difference between tests (i.e., perfect agreement), the 2 dot-dash lines (y = 16.81, −12.31) represent the 95% confidence interval for differences between pairs of individual measurements, and the 2 solid lines (y = 25, y = −25) represent the clinical acceptability criteria. Participant ID has been used as the data-point symbol. Green symbols represent clinically acceptable differences between measures (i.e., data points located in-between the 2 solid lines), whereas red symbols represent clinically unacceptable differences (i.e., data points located outside the 2 solid lines); there are no clinically unacceptable paired results for creatinine.

Article Snippet: A prospective, observational, single-center, clinical feasibility study (TRN: ISRCTN68116915), with N = 15 stable kidney transplant recipients, investigated blood potassium and creatinine results agreement between index self-tests at home (patient self-testing of capillary blood, using Abbott i-STAT Alinity analyzers [i-STAT]) and reference tests in clinic (staff sampled venous blood, analyzed with laboratory Siemens Advia Chemistry XPT analyzer) using Bland-Altman and error grid analysis.

Techniques:

Systematic review summary of papers comparing i-STAT and other POCT device measurements of creatinine and potassium to laboratory methods

Journal: Kidney International Reports

Article Title: Patient Self-Testing of Kidney Function at Home, a Prospective Clinical Feasibility Study in Kidney Transplant Recipients

doi: 10.1016/j.ekir.2023.03.003

Figure Lengend Snippet: Systematic review summary of papers comparing i-STAT and other POCT device measurements of creatinine and potassium to laboratory methods

Article Snippet: A prospective, observational, single-center, clinical feasibility study (TRN: ISRCTN68116915), with N = 15 stable kidney transplant recipients, investigated blood potassium and creatinine results agreement between index self-tests at home (patient self-testing of capillary blood, using Abbott i-STAT Alinity analyzers [i-STAT]) and reference tests in clinic (staff sampled venous blood, analyzed with laboratory Siemens Advia Chemistry XPT analyzer) using Bland-Altman and error grid analysis.

Techniques: Comparison